For the third year, the Michael J. Fox Foundation organized a concert benefit at Belmont University's Fisher Center for ...

Diagnosis of neurodegenerative disease is currently often made too late in the disease progression for effective treatment to ...

Hebrew University researchers say their innovative test can find tRNA fragments unique to the neurodegenerative disease ...

Parkinson’s Disease is often diagnosed only after significant brain damage has occurred, when most relevant neurons are ...

A new study has found important clues about the roles age, sex, hormonal changes and genetics play in how certain biomarkers for dementia are expressed in the blood, according to a study published on ...

Researchers have discovered a new biomarker for Parkinson’s that could be used to identify people at risk of the disease and profoundly change the way it is treated. The assay for a particular ...

An £80 blood test could help predict those who will develop Parkinson’s before they show symptoms of the disease, a new study ...

Precise mapping of a patient’s brain can enable a wider range of treatments, writes DR ROWLAND ILLING, chief medical officer of AWS.

Most patients are diagnosed when symptoms like tremors, stiffness, slow movement, and cognitive impairment appear, but by ...

A new study identifies a blood-based biomarker that detects pre-symptomatic Parkinson’s disease by measuring the ratio of ...

Health care providers, insurers and pharmaceutical companies are widely interested in the use of generative AI in their ...

By measuring the ratio between these biomarkers, the new test can distinguish pre-symptomatic Parkinson’s patients from healthy controls with an accuracy surpassing that of existing clinical ...